Lupin Limited Earns WHO Prequalification of Pretomanid Tablets

Lupin Limited, a leading pharmaceutical company based in India, received World Health Organization (WHO) prequalification for its 200mg pretomanid tablet. This achievement adds another manufacturer to the market for a critical component of WHO-endorsed six-month drug-resistant TB treatments. Having multiple producers strengthens the global supply of pretomanid, ensures consistent quality, and drives competition that helps further lower costs.